1. Home
  2. SBFM vs VSME Comparison

SBFM vs VSME Comparison

Compare SBFM & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • VSME
  • Stock Information
  • Founded
  • SBFM 2006
  • VSME 2013
  • Country
  • SBFM United States
  • VSME Hong Kong
  • Employees
  • SBFM N/A
  • VSME N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • VSME
  • Sector
  • SBFM Health Care
  • VSME
  • Exchange
  • SBFM Nasdaq
  • VSME Nasdaq
  • Market Cap
  • SBFM 3.7M
  • VSME 4.2M
  • IPO Year
  • SBFM N/A
  • VSME 2023
  • Fundamental
  • Price
  • SBFM $2.35
  • VSME $1.16
  • Analyst Decision
  • SBFM
  • VSME
  • Analyst Count
  • SBFM 0
  • VSME 0
  • Target Price
  • SBFM N/A
  • VSME N/A
  • AVG Volume (30 Days)
  • SBFM 151.4K
  • VSME 476.4K
  • Earning Date
  • SBFM 11-05-2024
  • VSME 11-26-2024
  • Dividend Yield
  • SBFM N/A
  • VSME N/A
  • EPS Growth
  • SBFM N/A
  • VSME N/A
  • EPS
  • SBFM N/A
  • VSME N/A
  • Revenue
  • SBFM $32,959,491.00
  • VSME $7,991,103.00
  • Revenue This Year
  • SBFM $86.70
  • VSME N/A
  • Revenue Next Year
  • SBFM $126.76
  • VSME N/A
  • P/E Ratio
  • SBFM N/A
  • VSME N/A
  • Revenue Growth
  • SBFM 61.94
  • VSME N/A
  • 52 Week Low
  • SBFM $2.25
  • VSME $0.65
  • 52 Week High
  • SBFM $638.00
  • VSME $6.26
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 25.54
  • VSME 44.45
  • Support Level
  • SBFM $2.58
  • VSME $1.10
  • Resistance Level
  • SBFM $2.86
  • VSME $1.62
  • Average True Range (ATR)
  • SBFM 0.17
  • VSME 0.21
  • MACD
  • SBFM -0.04
  • VSME -0.05
  • Stochastic Oscillator
  • SBFM 12.67
  • VSME 23.33

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.

Share on Social Networks: